Breakthrough in Rare Cancer Treatment at Malla Reddy Narayana Hospital

Malla Reddy Narayana Cancer Hospital in Hyderabad has achieved a groundbreaking medical feat by successfully treating a rare case of Primary Peritoneal Ewing’s Sarcoma. The procedure involved complex Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC), marking a significant advancement in abdominal cancer treatment.


Devdiscourse News Desk | Hyderabad | Updated: 22-04-2025 11:02 IST | Created: 22-04-2025 10:05 IST
Breakthrough in Rare Cancer Treatment at Malla Reddy Narayana Hospital
HCG Cancer Hospital Bengaluru sets a new benchmark for Personalized cancer care with the launch of India's first innovative 'Ethos Therapy', an AI-based adaptive radiation treatment Image Credit: ANI
  • Country:
  • India

Hyderabad's Malla Reddy Narayana Cancer Hospital announced a landmark medical achievement, successfully treating a rare case of Primary Peritoneal Ewing’s Sarcoma in a 24-year-old patient. The condition, known for its rarity and aggressive nature, was treated using cutting-edge technology and surgical precision.

The hospital's multidisciplinary oncology team, led by Dr. Harish Dara, performed a demanding 16-hour surgical procedure, including complete tumor removal and direct heated chemotherapy infusion via HIPEC. This innovative method targets residual cancer cells, optimizing chemotherapy effectiveness while preserving healthy tissues.

Dr. Ch. Bhadra Reddy, Chairman, highlighted the significance of the success, emphasizing the hospital's dedication to delivering advanced cancer care. The procedure's success underscores the facility's leadership in handling rare oncological conditions through state-of-the-art medical technology and patient-centered approach.

(With inputs from agencies.)

Give Feedback